magic ocean philippines

NEW YORK (AP) — The outgoing head of the nation’s top public health agency urged the next administration to maintain its focus and funding to keep Americans safe from emerging health threats. “We need to continue to do our global work at CDC to make sure we are stopping outbreaks at their source,” Dr. Mandy Cohen, director of the Centers for Disease Control and Prevention, said in an interview Monday with The Associated Press. “We need to keep that funding up. We need to keep the expertise up. We need to keep the diplomacy up.” Cohen, 46, will be leaving office in January after about 18 months in the job. President-elect Donald Trump on Friday night said he picked Dave Weldon , a former Congressman from Florida, to be the agency’s next chief. Cohen said she hasn’t met Weldon and doesn’t know him. She previously voiced concern about Robert F. Kennedy Jr., the anti-vaccine advocate and CDC critic nominated to oversee all federal public health agencies . People are also reading... The CDC, with a $9.2 billion core budget, is charged with protecting Americans from disease outbreaks and other public health threats. The staff is heavy with scientists — 60% have master’s degrees or doctorates. The last eight years have been perhaps the most difficult in the agency's history. The CDC once enjoyed a sterling international reputation for its expertise on infectious diseases and other causes of illness and death. But trust in the agency fell because of missteps during the early days of the COVID-19 pandemic, political attacks and resistance to infection-prevention measures like wearing masks and getting vaccinated. The CDC has four political appointees, out of about 13,000 employees. The rest serve no matter who is in the White House, with civil service protections against efforts to fire them for political reasons. Trump said during the campaign that he wants to convert many federal agency positions into political appointments, meaning those employees could be hired and fired by whoever wins the election. There’s also a proposal to split the agency in two: one to track disease data, and another focused on public health but with a limited ability to make policy recommendations. And then there’s a current budget proposal in Congress that would cut the agency’s funding by 22%. It would also eliminate the CDC’s National Center for Injury Prevention and Control, which works on topics like drownings, drug overdoses, suicides and and shooting deaths. Cohen said there’s reason to be proud of the agency’s work in recent years. The CDC has built partnerships to improve the availability of testing for different infections and to watch for signs of disease outbreaks by monitoring wastewater . There are emerging threats, as always, but no new, full-fledged public health emergencies, she said. The day after the Nov. 5 election, Cohen emailed CDC employees to urge them to keep going. “While the world may feel different with changes ahead — our mission has not changed,” she wrote. She said she’s not aware of any wave of worried CDC scientists heading for the doors because of the election results. “There is a difference between campaigning and governing,” she said. “I want to go into this in a way that we’re passing the baton.” Cohen said she doesn’t know what she’ll do next, other than spend time with her family in Raleigh, North Carolina, where her family maintained its residence while she ran the agency. Next year, for the first time, the CDC director will be subject to Senate confirmation, which could make for a gap before Trump's pick takes the helm. CDC Deputy Director Dr. Debra Houry has been assigned to help manage the transition. Aside from administration transition, the CDC has to face several looming threats. Officials this month confirmed the first U.S. case of a new form of mpox that was first seen in eastern Congo. There’s also the ongoing stream of bird flu cases , most of them mild illnesses seen in farmworkers who were in direct contact with infected cows or chickens. CDC officials say they believe the risk to the public remains low and that there’s no evidence it’s been spreading between people. “I don’t think we’re yet at a turning place. But does that mean it couldn’t change tomorrow? It could,” she said. The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content. Copyright 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission. Get local news delivered to your inbox!Jimmy Carter, in his own words: Memorable quotes from the former presidentNotices issued to six outlets in Kalamassery for food safety violationsmagic ocean philippines 。

None

The Aaron Rodgers experience in New York has fallen flat, which leaves the Jets again thinking about the future at quarterback amid a lost season that is essentially dead before Thanksgiving Day. Owner Woody Johnson wanted head coach Robert Saleh and general manager Joe Douglas to dump Rodgers for backup quarterback Tyrod Taylor a month into the campaign when the team was 2-2. The brass refused, and both Saleh and Douglas have been fired since. Rodgers has one year remaining on his contract, but the Jets can release him or trade him ahead of next season, which both seem more likely outcomes now than the soon to be 41-year-old returning to the franchise in 2025. Joe Camporeale/Getty Images Free agency is shaky at best, with Sam Darnold of the Minnesota Vikings -- formerly the No. 3 overall pick of the Jets in the 2018 NFL draft, who bombed out in New York after three seasons -- entering the 2025 class as arguably the top available QB alongside Pittsburgh Steelers backup Justin Fields . Trading for a Super Bowl-caliber signal caller is exceedingly difficult, as the Jets just proved after their failed attempt to do so via a deal for Rodgers with the Green Bay Packers just two years ago. That leaves New York with one option -- the 2025 draft. That isn't a foolproof plan either, despite the fact that were the draft held today, the Jets would select No. 6 overall . The reasons for uncertainty are two: first, the 2025 class isn't overly deep at the QB position. Second, New York is currently behind at least three teams in the Las Vegas Raiders , New York Giants and Tennessee Titans that are liable to look QB as well come April. Mark J. Rebilas-Imagn Images However, the Jacksonville Jaguars currently own the No. 1 pick and just inked QB Trevor Lawrence to a $275 million extension that ties the franchise to him through 2030. So, the first pick in the draft could essentially come down to a scenario where the best trade offer to the Jags wins the rights to Colorado Buffaloes signal caller, Shedeur Sanders . The Jets would undoubtedly need to include the No. 6 pick and more, likely another first-round selection in 2026 and then some, to move up the five spots to secure Sanders. However, doing so might also allow New York to fill its head coaching vacancy in the process. Jeff Ulbrich is the interim head coach, but the Jets could potentially replace him with Deion Sanders -- Shedeur Sanders' father and head coach at Colorado -- as a package deal. There are other teams certainly that would be interested in Shedeur Sanders as the QB of the future, and there may also be multiple franchises interested in adding the dynamic father-son duo. The Jets could get into that game by making a big move ahead of the draft and trading into the No. 1 spot, which is what it will likely take to bring what is otherwise a contending-caliber roster in New York into the Super Bowl conversation in the coming years. Related: Could Shedeur Sanders Be Aaron Rodgers' Replacement?

AP Business SummaryBrief at 6:28 p.m. ESTSocial media users said Hawk Tuah girl Hailey Welch will be arrested because of crypto scam. As people faced a huge loss after buying Hawk Tuah girl's cryptocurrency $HAWK, demands to arrest Hailey Welch were raised on social media. A law firm stepped up to assist victims who lost millions in the memecoin that crashed after the viral Hawk Tuah meme-fame girl launched it. Hailey Welch said they did not do any intentional wrongdoing. Many social media users debunked what she actually did and called it a scam. "Team hasn’t sold one token and not 1 KOL was given 1 free token. We tried to stop snipers as best we could through high fee’s in the start of launch on @MeteoraAG. Fee’s have now been dropped," Welch posted amid huge backlash. "Hailey I’m not even kidding when I say this, you are most likely going to prison," a social media user said. And several others threatened her with a lawsuit. What did the Hawk Tuah girl do? Hawk digital coin hit a a $490m market cap shortly after it launched on Wednesday, before suddenly losing more than 95% of its value within hours. YouTube cryptocurrency investigator Coffeezilla accused Welch of scamming investors with a "pump and dump" scheme where the people behind a coin hype up its price before launch, then sell it for profit. Welch said her team did not sell any of the tokens. Coffeezilla said Hailey Welch's team actually targeted her fans and exploited them as these fans are those who have never been involved in the crypto space and they did not target crypto bros because they would not buy her coin in all probability. "These people were unwilling to take any accountability" of the "Hawk Tuah scam", he claimed. In 2021, Kim Kardashian was fined $1.26m by US regulators after she failed to disclose that she had been paid to post an advert for a cryptocurrency scheme called EthereumMax. If Hailey Welch is sued and it's proved that she scammed her fans, she will be penalised but as of now claims that she would be going to jail are only social media speculations.

Ex-OpenAI engineer who raised legal concerns about the technology he helped build has diedOf Reforms and Dantsoho’s Election as PMAWCA ChairmanItaly's data protection authority said Friday it had fined OpenAI 15 million euros over the use of personal data by ChatGPT, closing a nearly two-year investigation. The Italian Data Protection Authority (GPDP) watchdog had temporarily blocked ChatGPT in Italy in March 2023 over privacy concerns, becoming the first Western country to take action against the popular AI chatbot. "The Data Protection Authority imposed a fine of 15 million euros on OpenAI, which was also calculated taking into account the company's cooperative attitude," it said Friday. The body said that OpenAI "did not notify the authority of the data breach it underwent in March 2023, it has processed users' personal data to train ChatGPT without first identifying an appropriate legal basis and has violated the principle of transparency and the related information obligations toward users". In addition, OpenAI "has not provided for mechanisms for age verification, which could lead to the risk of exposing children under 13 to inappropriate responses", it added. As well as the fine, the authority said it had ordered OpenAI to carry out a six-month broadcast, print and Internet campaign to promote public understanding of ChatGPT. You can unsubscribe at any time by clicking the link in the footer of our emails. We use as our marketing platform. By subscribing, you acknowledge that your information will be transferred to Mailchimp for processing.

WARMINGTON: Masked Christmas shoppers on bail hunt for gifts with hammersUSA News Group Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC , Dec. 20, 2024 /PRNewswire/ -- USA News Group News Commentary – The American Cancer Society has published its Advances in Oncology – 2024 Research Highlights , underscoring major strides in cancer research and ongoing innovation. However, the optimism is tempered by a troubling finding: a significant global rise in early-onset colorectal cancer cases . This unsettling trend comes as the medical community grapples with the lingering effects of the COVID-19 pandemic. A recent Nature article revealed how disruptions in cancer care—particularly delays in screenings, diagnoses, and treatments—have likely exacerbated the progression of advanced disease, diminished survival rates, and complicated long-term data analysis. Still, the oncology field continues to push forward with promising developments emerging from key innovators like O ncolytics Biotech Inc. (NASDAQ: ONCY) (TSX: ONC), Cardiff Oncology, Inc. (NASDAQ: CRDF), Personalis, Inc. (NASDAQ: PSNL), Tempus AI, Inc. (NASDAQ: TEM), and Checkpoint Therapeutics, Inc. (NASDAQ: CKPT). The article continued: Additionally, the American Cancer Society has spotlighted an alarming rise in cancer incidence and mortality among younger age groups. Analysts at Exactitude Consultancy anticipate that the global Cancer Immunotherapy Market will expand at a robust 12.84% CAGR, reaching $258.22 billion by 2031 —a clear indicator of oncology's rapid growth and critical importance. Oncolytics Biotech® to Present Promising Pelareorep Data in Pancreatic and Anal Cancers at ASCO GI Symposium Oncolytics Biotech Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced the presentation of two data sets through two abstracts showcasing pelareorep's potential in difficult-to-treat gastrointestinal cancers, which were accepted and will be presented at the 2025 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium in San Francisco January 23-25, 2025 . "We are enthusiastic about pelareorep's applicability across multiple gastrointestinal cancer indications, including pancreatic and anal cancer," said Tom Heineman , M.D., Ph.D., Chief Medical Officer of Oncolytics . "Pelareorep engages patients' immune systems to help make commonly used chemotherapies and checkpoint inhibitors, such as atezolizumab, more effective in fighting cancer. This offers the promise of delaying disease progression and improving survival in patients with these devasting diseases. Given the versatility of pelareorep, we see multiple clinical and regulatory options for bringing this promising medicine to patients." Oncolytics will present two key data sets from the GOBLET study, with preliminary safety and tumor response results for the relapsed anal carcinoma cohort treated with pelareorep and atezolizumab presented in Poster Session C on January 25, 2025 , from 7:00 to 7:55 a.m. PT . Additionally, results from the safety run-in phase for first-line metastatic pancreatic ductal adenocarcinoma patients treated with pelareorep, modified FOLFIRINOX, with and without atezolizumab will be presented in Poster Session B on January 24, 2025 , from 11:30 a.m. to 1:00 p.m. PT . Both abstracts will be available on the ASCO Gastrointestinal Cancers Symposium website at 5:00 p.m. ET on January 21, 2025 . CONTINUED... Read this and more news for Oncolytics Biotech at: https://usanewsgroup.com/2023/10/02/the-most-undervalued-oncolytics-company-on-the-nasdaq/ In other recent industry developments and happenings in the market include: Cardiff Oncology, Inc. (NASDAQ: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, recently announced positive initial data from CRDF-004, a randomized, Phase 2 clinical trial evaluating onvansertib in combination with standard-of-care (SoC) in patients with first-line RAS-mutated metastatic colorectal cancer (mCRC). Efficacy and safety data are for all evaluable patients as of a November 26, 2024 , data cut-off date, and all efficacy data are determined by a blinded, independent central review (BICR) of each patient's tumor scan. "We are highly encouraged by the robust efficacy signal and favorable safety profile observed with onvansertib plus standard-of-care from the first 30 evaluable patients in our randomized first-line RAS-mutated mCRC CRDF-004 trial," said Fairooz Kabbinavar, MD, FACP, Chief Medical Officer of Cardiff Oncology . "Our data shows an objective response rate of 64% in patients receiving the 30 mg dose of onvansertib in combination with standard of care, significantly higher than the 33% objective response rate observed in the control arms of standard of care alone. In addition, as can be seen in the spider plots, we are observing deeper tumor response in patients receiving the 30mg dose of onvansertib compared to those receiving the 20mg dose with similar safety profiles for both doses." Personalis, Inc. (NASDAQ: PSNL), a developer of advanced cancer genomic tests and analytics, and Tempus AI, Inc. (NASDAQ: TEM), an AI-powered healthcare technology company, recently announced they've expanded their commercial relationship. Both companies agreed in November 2023 to collaborate and bring ultra-sensitive MRD testing to market and launched their efforts at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting. Tempus is serving as the exclusive commercial diagnostic partner for Personalis' ultra-sensitive tumor-informed MRD product, NeXT Personal® Dx, for broad patient adoption in breast and lung cancers, and for immunotherapy monitoring across all solid tumors. "While we already offer NeXT Personal through our own biopharma channel, we are pleased to leverage Tempus' integrated platform as well for these biopharma customers who desire to combine NeXT Personal with other Tempus products," said Chris Hall , CEO of Personalis . "We believe the expansion of the relationship with Tempus will accelerate market penetration of our leading ultra-sensitive MRD platform and allow us to better capitalize on the opportunity." Under this expanded relationship, Tempus will be enabled to offer Personalis' NeXT Personal MRD product to pharmaceutical and biotech customers who wish to bundle MRD testing with other Tempus offerings in a given study. Checkpoint Therapeutics, Inc. (NASDAQ: CKPT), a commercial-stage immunotherapy and targeted oncology company focused on novel treatments for patients with solid tumor cancers, recently announced that the FDA approved its UNLOXCYTTM (cosibelimab-ipdl) for the treatment of adults with metastatic cutaneous squamous cell carcinoma (cSCC) or locally advanced cSCC who are not candidates for curative surgery or curative radiation. UNLOXCYT is the first and only programmed death ligand-1 (PD-L1) blocking antibody to receive FDA marketing approval for this indication. "[This] FDA approval of UNLOXCYT – the first marketing approval for our company – is a significant milestone both for Checkpoint and for patients with advanced cSCC," said James Oliviero , President and CEO of Checkpoin t. "This approval marks Checkpoint's transformation to a commercial-stage company, with the opportunity to compete in a U.S. market estimated to exceed $1 billion annually, where we believe UNLOXCYT offers a differentiated treatment option versus available therapies by binding to PD-L1, rather than programmed death receptor-1 (PD-1), to release the inhibitory effects of PD-L1 on the anti-tumor immune response. Additionally, UNLOXCYT has demonstrated the ability to induce antibody-dependent cell-mediated cytotoxicity (ADCC), another potential differentiating feature of the drug compared to existing marketed therapies for patients with cSCC." Source: https://usanewsgroup.com/2024/09/21/is-oncolytics-biotech-the-markets-most-undervalued-cancer-opportunity/ CONTACT: USA NEWS GROUP info@usanewsgroup.com (604) 265-2873 DISCLAIMER: Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. USA News Group is a wholly-owned subsidiary of Market IQ Media Group, Inc. ("MIQ"). MIQ has been paid a fee for Oncolytics Biotech Inc. advertising and digital media from the company directly. There may be 3rd parties who may have shares of Oncolytics Biotech Inc., and may liquidate their shares which could have a negative effect on the price of the stock. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this publication as the basis for any investment decision. The owner/operator of MIQ own shares of Oncolytics Biotech Inc. which were purchased in the open market, and reserve the right to buy and sell, and will buy and sell shares of Oncolytics Biotech Inc. at any time without any further notice commencing immediately and ongoing. We also expect further compensation as an ongoing digital media effort to increase visibility for the company, no further notice will be given, but let this disclaimer serve as notice that all material, including this article, which is disseminated by MIQ has been approved by Oncolytics Biotech Inc.; this is a paid advertisement, we currently own shares of Oncolytics Biotech Inc. and will buy and sell shares of the company in the open market, or through private placements, and/or other investment vehicles. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. View original content: https://www.prnewswire.com/news-releases/oncology-advancements-accelerate-amid-rising-early-onset-cancer-diagnoses-302337555.html SOURCE USA News GroupThe National Anti-Corruption Commission (NACC) denies it has been lobbied to change a commissioner to sway an investigation into former premier Thaksin Shinawatra 's police hospital detention. NACC secretary-general Sarote Phuengramphan, who is also the agency's spokesman, denied lobbying had taken place to change the commissioner in charge of the case, as reported. The lobbying was alleged by activist and former red shirt leader Jatuporn Prompan who claimed during a live session on Facebook on Dec 25 that an attempt was made to coax Ekkawit Watchawanku into stepping aside as commissioner in charge of the Thaksin hospital detention case. Mr Sarote said on Sunday the NACC has accepted the case for probe with the entire panel of commissioners supervising the process. The NACC earlier this month agreed to investigate officials accused of letting Thaksin stay in relative comfort at the Police General Hospital (PGH) instead of prison. Thaksin, sentenced to eight years in prison across three cases before receiving royal clemency, reducing his term to one year, was detained in a ward on the 14th floor of the hospital for approximately six months. He was paroled and discharged from the PGH on Feb 18, completing his one-year prison term on Aug 31. The commission decided to take up the case in response to claims that officials at the Department of Corrections and the hospital sent Thaksin to the PGH so he did not have to serve his term in prison. Thaksin spent 180 days at the PGH, although he was believed not to have been seriously ill. The NACC said it had gathered enough facts, witnesses and evidence to conduct the probe so decided to proceed with the case. The investigation would focus on 12 officials at the Department of Corrections and the PGH, the commission said. On his Facebook session, Mr Jatuporn said Mr Ekkawit was subject to lobbying to stand down in favour of another commissioner. The activist suggested the lobbying may have come from someone within the commission. He said Mr Ekkawit, a former Supreme Court chief justice, assumed a prominent role in the probe and it was natural for him to be target of lobbying to have him sidelined. Although a switch of commissioner in charge may not end in the case being dropped, it would at least delay the investigation, Mr Jatuporn said. However, Mr Jatuporn said it was up to Mr Ekkawit if he would cave in to pressure. "My message to NACC is simply this. The country had endured enough tribulations. The agency must recognise that there are no secrets in the world," he said.

As businesses in Johannesburg gear up for 2025, aligning workforce strategies with organizational objectives is paramount. Partnering with the right recruitment agency can significantly enhance talent acquisition efforts, streamline recruitment processes, and ensure access to top-tier candidates. This guide offers insights into selecting a recruitment agency in Johannesburg that aligns with your company's goals. Understanding your workforce needs in 2025 As Johannesburg businesses prepare for a rapidly evolving market in 2025, understanding the city's unique workforce dynamics is crucial. Tailoring your recruitment strategy to meet these demands ensures your organization remains competitive and agile. Identify emerging skill gaps Analyse your industry's trends and determine the critical skills needed to align with future objectives. In Johannesburg, sectors like technology, finance, and logistics are experiencing high demand for specialized expertise. Define flexible workforce models Evaluate whether permanent, temporary, or contract roles are most suited to your goals. Balancing these options can help you stay adaptable in an unpredictable business environment. Account for seasonal hiring trends Johannesburg's economic landscape often includes seasonal peaks, particularly in retail, tourism, and manufacturing. Planning for these fluctuations will help you secure the right talent when it's needed most. Taking these steps ensures that your hiring approach aligns seamlessly with Johannesburg's workforce landscape in 2025. Evaluating recruitment agencies Choosing the right recruitment agency is a critical step toward building a workforce that supports your business objectives. In Johannesburg, where industries are diverse and competitive, a... Partnered ContentWA’s Liberal party leader has thrown down the gauntlet to challengers after polling predicted the “immediate appointment” of Perth Lord Mayor Basil Zempilas as leader would allow the flailing party to gain back five seats at the election. Libby Mettam has labelled the polling, commissioned by a mystery Perth business person with links to the party, as ‘flawed and clearly biased’, and has challenged anyone who wishes to be leader to move a no confidence motion against her during a meeting today. “Constant undermining of leaders, especially from the shadows within, is a sad reality in politics today,” she said. “But rather than weaken me it has made me stronger and more determined to succeed - not for myself - but for the people of Western Australia who deserve better. “I’m not a quitter, I’m a fighter.” The polling, published in today, suggested another catastrophic election for the Liberals come election day in March. The party currently holds just three out of 59 seats in the Legislative Assembly, with the polling predicting the party has gone backwards since the 2021 election bloodbath, losing ground in 14 key metropolitan seats. Under Mettam, the party is predicted to suffer a 4 per cent drop, with the Liberal primary vote falling to 31 per cent in blue-ribbon seats like Churchlands and Nedlands. On the flip-side, the polling suggests a 3 per cent swing towards the Liberal party under Zempilas’ leadership, and a 38 per cent primary vote. The research, carried out by Sodali and Co, said Zempilas’ leadership could deliver wins in Churchlands, Nedlands, Carine, Bateman and Scarborough. Here’s what’s making news this morning. Mostly sunny today with a top of 25 degrees. Good morning readers, and welcome to our live news blog for Tuesday, November 26. Making headlines this morning, Perth is tipped to outperform the rest of the country in property price growth with forecasts in 2025. Meanwhile, cast your mind back to your school days – or, rather, the very end of your school days and the next step you took. Did you get a high score to enrol in the university degree of your choice? Did you decide to bypass the ATAR exams – or the equivalent of the era, for those older readers – and go straight into an apprenticeship? What about if you got a high ATAR score, but decided to go down the vocational pathway? That’s the situation Ellie Wotherspoon found herself in, having graduated from school with an impressive ATAR of 91. With an ATAR like that, Wotherspoon could have studied law, or medicine, or molecular science. But currently, she’s an electrician working on one of oil and gas giant Woodside’s offshore rigs. And regular readers of this blog – and more broadly – would know we’ve got our fingers on the pulse of this great state’s dining scene. And today, food writer Max Veenhuyzen fills you in on the latest happenings in the world of pastry cases with, er, fillings. From creative fillings to stocking choc milk and ginger beer in the fridge, a cosy nostalgia-fuelled takeaway in Leederville celebrates both the past and the future. Always on the lookout for a great pie? Thanks again for joining us today, stay with us as we bring you all the news you need to know.Penn State kicks off Sunshine Slam by cruising past FordhamTesla Afterhours! Gaming’s Uncharted Frontier?

Vikings staying on track and in control behind Sam Darnold's composure and confidenceNick Kern came off the bench for 20 points and 13 rebounds as Penn State remained unbeaten with an 85-66 thumping of Fordham in a semifinal of the Sunshine Slam on Monday in Daytona Beach, Fla. The Nittany Lions (6-0), who will play either San Francisco or Clemson for the tournament title on Tuesday, put four other players in double figures. Zach Hicks scored 16 points, while Puff Johnson added 15. Ace Baldwin and Yanic Konan Niederhauser each chipped in 12 points. Penn State sank nearly 53 percent of its field goal attempts and earned a 38-30 advantage on the boards, more than enough to offset missing 12 of its 32 foul shots. Four players reached double figures for the Rams (3-4), led by 15 points apiece from Jackie Johnson III and reserve Joshua Rivera. Romad Dean and Jahmere Tripp each added 13. Fordham was as close as 56-49 after Tripp made a layup with 14:25 left in the game. But the Nittany Lions responded with a 16-1 run, capped with a layup by Kern for a 22-point lead at the 9:33 mark, and they never looked back. The main storyline prior to tipoff was whether Penn State could continue its torrid early start that saw it come into the day leading Division I in steals and ranked second in scoring at 98.2 points per game. The Nittany Lions certainly played to their billing for most of the first half, establishing a 21-8 lead at the 10:08 mark via Hicks' three-point play. Fordham predictably struggled early with the pressure defense, committing four turnovers in the first four minutes. But the Rams got their bearings over the last 10 minutes and made some shots. They got as close as four on two occasions late in the half before Penn State pushed the lead to 42-34 at the half. The officials were busy in the half, calling 23 fouls and administering 27 free throws. --Field Level MediaEach year, at least 100,000 kids call into the North American Aerospace Defense Command to inquire about Santa’s location. Millions more follow online — in nine languages — as St. Nick swoops along the earth's meridians. “We fully expect for Santa to take flight on Dec. 24 and NORAD will track him," the U.S.-Canadian agency said in a statement. On any other night, NORAD is scanning the heavens for potential threats , such as last year's Chinese spy balloon . But on Christmas Eve, volunteers in Colorado Springs, Colorado, are fielding questions like, “When is Santa coming to my house?” and, “Am I on the naughty or nice list?” The endeavor is supported by local and corporate sponsors, who also help shield the tradition from Washington dysfunction. Bob Sommers, 63, a civilian contractor and NORAD volunteer, told The Associated Press that there are "screams and giggles and laughter” when families call in, usually on speakerphone. Sommers often says on the call that everyone must be asleep before Santa arrives, prompting parents to say, "Do you hear what he said? We got to go to bed early." NORAD's annual tracking of Santa has endured since the Cold War , predating ugly sweater parties and Mariah Carey classics . Here's how it began and why the phones keep ringing. It started with a child's accidental phone call in 1955. The Colorado Springs newspaper printed a Sears advertisement that encouraged children to call Santa, listing a phone number. A boy called. But he reached the Continental Air Defense Command, now NORAD, a joint U.S. and Canadian effort to spot potential enemy attacks. Tensions were growing with the Soviet Union, along with anxieties about nuclear war. Air Force Col. Harry W. Shoup picked up an emergency-only “red phone” and was greeted by a tiny voice that began to recite a Christmas wish list. “He went on a little bit, and he takes a breath, then says, ‘Hey, you’re not Santa,’” Shoup told The Associated Press in 1999. Realizing an explanation would be lost on the youngster, Shoup summoned a deep, jolly voice and replied, “Ho, ho, ho! Yes, I am Santa Claus. Have you been a good boy?” Shoup said he learned from the boy's mother that Sears mistakenly printed the top-secret number. He hung up, but the phone soon rang again with a young girl reciting her Christmas list. Fifty calls a day followed, he said. In the pre-digital age, the agency used a 60-by-80-foot (18-by-24-meter) plexiglass map of North America to track unidentified objects. A staff member jokingly drew Santa and his sleigh over the North Pole. The tradition was born. “Note to the kiddies,” began an AP story from Colorado Springs on Dec. 23, 1955. “Santa Claus Friday was assured safe passage into the United States by the Continental Air Defense Command.” In a likely reference to the Soviets, the article noted that Santa was guarded against possible attack from "those who do not believe in Christmas.” Some grinchy journalists have nitpicked Shoup's story, questioning whether a misprint or a misdial prompted the boy's call. In 2014, tech news site Gizmodo cited an International News Service story from Dec. 1, 1955, about a child's call to Shoup. Published in the Pasadena Independent, the article said the child reversed two digits in the Sears number. "When a childish voice asked COC commander Col. Harry Shoup, if there was a Santa Claus at the North Pole, he answered much more roughly than he should — considering the season: ‘There may be a guy called Santa Claus at the North Pole, but he’s not the one I worry about coming from that direction,'" Shoup said in the brief piece. In 2015, The Atlantic magazine doubted the flood of calls to the secret line, while noting that Shoup had a flair for public relations. Phone calls aside, Shoup was indeed media savvy. In 1986, he told the Scripps Howard News Service that he recognized an opportunity when a staff member drew Santa on the glass map in 1955. A lieutenant colonel promised to have it erased. But Shoup said, “You leave it right there,” and summoned public affairs. Shoup wanted to boost morale for the troops and public alike. “Why, it made the military look good — like we’re not all a bunch of snobs who don’t care about Santa Claus,” he said. Shoup died in 2009. His children told the StoryCorps podcast in 2014 that it was a misprinted Sears ad that prompted the phone calls. “And later in life he got letters from all over the world,” said Terri Van Keuren, a daughter. "People saying ‘Thank you, Colonel, for having, you know, this sense of humor.’” NORAD's tradition is one of the few modern additions to the centuries-old Santa story that have endured, according to Gerry Bowler, a Canadian historian who spoke to the AP in 2010. Ad campaigns or movies try to “kidnap” Santa for commercial purposes, said Bowler, who wrote “Santa Claus: A Biography.” NORAD, by contrast, takes an essential element of Santa's story and views it through a technological lens. In a recent interview with the AP, Air Force Lt. Gen. Case Cunningham explained that NORAD radars in Alaska and Canada — known as the northern warning system — are the first to detect Santa. He leaves the North Pole and typically heads for the international dateline in the Pacific Ocean. From there he moves west, following the night. “That's when the satellite systems we use to track and identify targets of interest every single day start to kick in,” Cunningham said. “A probably little-known fact is that Rudolph’s nose that glows red emanates a lot of heat. And so those satellites track (Santa) through that heat source.” NORAD has an app and website, www.noradsanta.org , that will track Santa on Christmas Eve from 4 a.m. to midnight, mountain standard time. People can call 1-877-HI-NORAD to ask live operators about Santa’s location from 6 a.m. to midnight, mountain time.

Louisiana judge halts state police plans to clear New Orleans homeless camps before ThanksgivingPlane Crash Kills 179 In Worst Airline Disaster In S Korea